-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27

Benzinga·09/02/2026 15:10:39
Listen to the news
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.